WES revealed a stop-gain mutation (c.799C > T; p.R267X) in the VPS13A gene while no mutation was found in the XK gene, confirming the patient as a case of ChAc and overruling the possibility of McLeod syndrome. This evidence concerns the gene VPS13A and McLeod neuroacanthocytosis syndrome.